Abstract
The incidence of colorectal cancer among adults aged less than 50 is rising. Patients with early-onset colorectal cancer are more likely to present with advanced disease stage with requirements for multimodal treatment. Younger patients appear to have higher rates of treatment-related toxicities, giving rise to unique challenges for these patients. The impact of treatment-related morbidity on quality of life can be overlooked. Survivorship issues are increasingly relevant owing to the potential for long-term survival following treatment. Striking a balance between treating early-onset colorectal cancer while preserving bowel, bladder, sexual function, and fertility is challenging yet imperative.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
AlZaabi A, AlHarrasi A, AlMusalami A, AlMahyijari N, Al Hinai K, Aladawi H, Al-Shamsi HO (2022) Early onset colorectal cancer: challenges across the cancer care continuum. Ann Med Surg 82:104453
André T, Iveson T, Labianca R, Meyerhardt JA, Souglakos I, Yoshino T, Paul J, Sobrero A, Taieb J, Shields AF, Ohtsu A, Grothey A, Sargent DJ (2013) The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) collaboration: prospective combined analysis of phase III trials investigating duration of adjuvant therapy with the FOLFOX (FOLFOX4 or modified FOLFOX6) or XELOX (3 versus 6 months) regimen for patients with stage III colon cancer: trial design and current status. Curr Colorectal Cancer Rep 9(3):261–269
Andreyev HJN (2015) Pelvic radiation disease. Color Dis 17(1):2–6
Andreyev HJN, Wotherspoon A, Denham JW, Hauer-Jensen M (2010) Defining pelvic-radiation disease for the survivorship era. Lancet Oncol 11(4):310–312
Andreyev HJN, Wotherspoon A, Denham JW, Hauer-Jensen M (2011) “Pelvic radiation disease”: new understanding and new solutions for a new disease in the era of cancer survivorship. Scand J Gastroenterol 46(4):389–397
Bahadoer RR, Peeters KCMJ, Beets GL, Figueiredo NL, Bastiaannet E, Vahrmeijer A, Temmink SJD, Kranenbarg WMEM-K, Roodvoets AGH, Habr-Gama A, Perez RO, van de Velde CJH, Hilling DE, W. the International and C. Wait Database (2022) Watch and wait after a clinical complete response in rectal cancer patients younger than 50 years. Br J Surg 109(1):114–120
Bailey CE, Tran Cao HS, Hu C-Y, Chang GJ, Feig BW, Rodriguez-Bigas MA, Nguyen ST, Skibber JM, You YN (2015) Functional deficits and symptoms of long-term survivors of colorectal cancer treated by multimodality therapy differ by age at diagnosis. J Gastrointest Surg 19(1):180–188; discussio 188
Baldwin CM, Grant M, Wendel C, Hornbrook MC, Herrinton LJ, McMullen C, Krouse RS (2009) Gender differences in sleep disruption and fatigue on quality of life among persons with ostomies. J Clin Sleep Med 5(4):335–343
Beets GL (2021) Colorectal cancer immunotherapy: a treatment quantum leap. Br J Surg 108(8):877–878
Beraldo FB, Yusuf SA, Palma RT, Kharmandayan S, Gonçalves JE, Waisberg J (2015) Urinary dysfunction after surgical treatment for rectal cancer. Arq Gastroenterol 52(3):180–185
Bosset JF, Calais G, Mineur L, Maingon P, Stojanovic-Rundic S, Bensadoun RJ, Bardet E, Beny A, Ollier JC, Bolla M, Marchal D, Van Laethem JL, Klein V, Giralt J, Clavère P, Glanzmann C, Cellier P, Collette L (2014) Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. Lancet Oncol 15(2):184–190
Bregendahl S, Emmertsen KJ, Lindegaard JC, Laurberg S (2015) Urinary and sexual dysfunction in women after resection with and without preoperative radiotherapy for rectal cancer: a population-based cross-sectional study. Color Dis 17(1):26–37
Brown S, Greenfield D, Thompson J (2016) Knowledge and awareness of long-term and late treatment consequences amongst colorectal cancer survivors: a qualitative study. Eur J Oncol Nurs 20:191–198
Buccafusca G, Proserpio I, Tralongo AC, Rametta Giuliano S, Tralongo P (2019) Early colorectal cancer: diagnosis, treatment and survivorship care. Crit Rev Oncol Hematol 136:20–30
Cotrim H, Pereira G (2008) Impact of colorectal cancer on patient and family: implications for care. Eur J Oncol Nurs 12(3):217–226
Dalsania RM, Shah KP, Stotsky-Himelfarb E, Hoffe S, Willingham FF (2021) Management of long-term toxicity from pelvic radiation therapy. Am Soc Clin Oncol Educ Book 41:1–11
Deidda S, Elmore U, Rosati R, De Nardi P, Vignali A, Puccetti F, Spolverato G, Capelli G, Zuin M, Muratore A, Danna R, Calabrò M, Guerrieri M, Ortenzi M, Ghiselli R, Scabini S, Aprile A, Pertile D, Sammarco G, Gallo G, Sena G, Coco C, Rizzo G, Pafundi DP, Belluco C, Innocente R, Degiuli M, Reddavid R, Puca L, Delrio P, Rega D, Conti P, Pastorino A, Zorcolo L, Pucciarelli S, Aschele C, Restivo A (2021) Association of delayed surgery with oncologic long-term outcomes in patients with locally advanced rectal cancer not responding to preoperative chemoradiation. JAMA Surg 156(12):1141–1149
den Bakker CM, Anema JR, Huirne JAF, Twisk J, Bonjer HJ, Schaafsma FG (2020) Predicting return to work among patients with colorectal cancer. Br J Surg 107(1):140–148
Eng C, Jácome AA, Agarwal R, Hayat MH, Byndloss MX, Holowatyj AN, Bailey C, Lieu CH (2022) A comprehensive framework for early-onset colorectal cancer research. Lancet Oncol 23(3):e116–e128
Ganesh K, Stadler ZK, Cercek A, Mendelsohn RB, Shia J, Segal NH, Diaz LA Jr (2019) Immunotherapy in colorectal cancer: rationale, challenges and potential. Nat Rev Gastroenterol Hepatol 16(6):361–375
Garcia-Aguilar J, Patil S, Kim JK, Yuval JB, Thompson H, Verheij F, Lee M, Saltz LB, o. b. o. t. O. Consortium (2020) Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial. J Clin Oncol 38(15_suppl):4008–4008
Garcia-Aguilar J, Patil S, Gollub MJ, Kim JK, Yuval JB, Thompson HM, Verheij FS, Omer DM, Lee M, Dunne RF, Marcet J, Cataldo P, Polite B, Herzig DO, Liska D, Oommen S, Friel CM, Ternent C, Coveler AL, Hunt S, Gregory A, Varma MG, Bello BL, Carmichael JC, Krauss J, Gleisner A, Paty PB, Weiser MR, Nash GM, Pappou E, Guillem JG, Temple L, Wei IH, Widmar M, Lin S, Segal NH, Cercek A, Yaeger R, Smith JJ, Goodman KA, Wu AJ, Saltz LB (2022) Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol 40(23):2546–2556
Guckenberger M, Saur G, Wehner D, Thalheimer A, Kim M, Germer CT, Flentje M (2013) Long-term quality-of-life after neoadjuvant short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer. Radiother Oncol 108(2):326–330
Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U Jr, Silva e Sousa AH Jr, Campos FG, Kiss DR, Gama-Rodrigues J (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240(4):711–717. discussion 717-718
Handmer M, Martin J, Tiu A (2020) Costing urologic complications following pelvic radiation therapy. Urology 140:64–69
Ho MY, McBride ML, Gotay C, Grunfeld E, Earle CC, Relova S, Tsonis M, Ruan JY, Chang JT, Cheung WY (2016) A qualitative focus group study to identify the needs of survivors of stage II and III colorectal cancer. Psychooncology 25(12):1470–1476
Jannin A, Penel N, Ladsous M, Vantyghem MC, Do Cao C (2019) Tyrosine kinase inhibitors and immune checkpoint inhibitors-induced thyroid disorders. Crit Rev Oncol Hematol 141:23–35
Johdi NA, Sukor NF (2020) Colorectal cancer immunotherapy: options and strategies. Front Immunol 11:1624
Kanani A, Veen T, Søreide K (2021) Neoadjuvant immunotherapy in primary and metastatic colorectal cancer. Br J Surg 108(12):1417–1425
Klopp AH, Yeung AR, Deshmukh S, Gil KM, Wenzel L, Westin SN, Gifford K, Gaffney DK, Small W Jr, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Pugh SL, Kachnic LA, Bruner DW (2018) Patient-reported toxicity during pelvic intensity-modulated radiation therapy: NRG oncology-RTOG 1203. J Clin Oncol 36(24):2538–2544
Kneuertz PJ, Chang GJ, Hu C-Y, Rodriguez-Bigas MA, Eng C, Vilar E, Skibber JM, Feig BW, Cormier JN, You YN (2015) Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains. JAMA Surg 150(5):402–409
Kong JC, Soucisse M, Michael M, Tie J, Ngan SY, Leong T, McCormick J, Warrier SK, Heriot AG (2021) Total neoadjuvant therapy in locally advanced rectal cancer: a systematic review and metaanalysis of oncological and operative outcomes. Ann Surg Oncol 28(12):7476–7486
Kort JD, Eisenberg ML, Millheiser LS, Westphal LM (2014) Fertility issues in cancer survivorship. CA Cancer J Clin 64(2):118–134
Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, Lu S, Kemberling H, Wilt C, Luber BS, Wong F, Azad NS, Rucki AA, Laheru D, Donehower R, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Greten TF, Duffy AG, Ciombor KK, Eyring AD, Lam BH, Joe A, Kang SP, Holdhoff M, Danilova L, Cope L, Meyer C, Zhou S, Goldberg RM, Armstrong DK, Bever KM, Fader AN, Taube J, Housseau F, Spetzler D, **ao N, Pardoll DM, Papadopoulos N, Kinzler KW, Eshleman JR, Vogelstein B, Anders RA, Diaz LA Jr (2017) Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science 357(6349):409–413
Lim CYS, Laidsaar-Powell RC, Young JM, Kao SC, Zhang Y, Butow P (2021) Colorectal cancer survivorship: a systematic review and thematic synthesis of qualitative research. Eur J Cancer Care (Engl) 30(4):e13421
Lobo N, Kulkarni M, Hughes S, Nair R, Khan MS, Thurairaja R (2018) Urologic complications following pelvic radiotherapy. Urology 122:1–9
Ludmir EB, Palta M, Willett CG, Czito BG (2017) Total neoadjuvant therapy for rectal cancer: an emerging option. Cancer 123(9):1497–1506
Maltaris T, Seufert R, Fischl F, Schaffrath M, Pollow K, Koelbl H, Dittrich R (2007) The effect of cancer treatment on female fertility and strategies for preserving fertility. Eur J Obstet Gynecol Reprod Biol 130(2):148–155
Mols F, Beijers T, Vreugdenhil G, van de Poll-Franse L (2014) Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review. Support Care Cancer 22(8):2261–2269
Nappi A, Berretta M, Romano C, Tafuto S, Cassata A, Casaretti R, Silvestro L, Divitiis C, Alessandrini L, Fiorica F, Ottaiano A, Nasti G (2018) Metastatic colorectal cancer: role of target therapies and future perspectives. Curr Cancer Drug Targets 18(5):421–429
Park IJ, You YN, Agarwal A, Skibber JM, Rodriguez-Bigas MA, Eng C, Feig BW, Das P, Krishnan S, Crane CH, Hu CY, Chang GJ (2012) Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol 30(15):1770–1776
Partridge AH, Gelber S, Peppercorn J, Sampson E, Knudsen K, Laufer M, Rosenberg R, Przypyszny M, Rein A, Winer EP (2004) Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 22(20):4174–4183
Perl G, Nordheimer S, Lando S, Benedict C, Brenner B, Perry S, Shmoisman G, Purim O, Amit L, Stemmer SM, Ben-Aharon I (2016) Young patients and gastrointestinal (GI) tract malignancies – are we addressing the unmet needs? BMC Cancer 16(1):630
Pollack J, Holm T, Cedermark B, Altman D, Holmström B, Glimelius B, Mellgren A (2006) Late adverse effects of short-course preoperative radiotherapy in rectal cancer. Br J Surg 93(12):1519–1525
Ramos-Casals M, Brahmer JR, Callahan MK, Flores-Chávez A, Keegan N, Khamashta MA, Lambotte O, Mariette X, Prat A, Suárez-Almazor ME (2020) Immune-related adverse events of checkpoint inhibitors. Nat Rev Dis Primers 6(1):38
REACCT Collaborative (2022a) Impact of microsatellite status in early-onset colonic cancer. Br J Surg 109(7):632–636
REACCT Collaborative (2022b) Microsatellite instability in young patients with rectal cancer: molecular findings and treatment response. Br J Surg 109(3):251–255
REACCT Collaborative (2022c) Post-operative functional outcomes in early age onset rectal cancer. Front Oncol 12:868359
Reese JB, Finan PH, Haythornthwaite JA, Kadan M, Regan KR, Herman JM, Efron J, Diaz LA, Azad NS (2014) Gastrointestinal ostomies and sexual outcomes: a comparison of colorectal cancer patients by ostomy status. Support Care Cancer 22(2):461–468
Reese JB, Handorf E, Haythornthwaite JA (2018) Sexual quality of life, body image distress, and psychosocial outcomes in colorectal cancer: a longitudinal study. Support Care Cancer 26(10):3431–3440
Sakamoto N, Takiguchi S, Komatsu H, Okuyama T, Nakaguchi T, Kubota Y, Ito Y, Sugano K, Wada M, Akechi T (2017) Supportive care needs and psychological distress and/or quality of life in ambulatory advanced colorectal cancer patients receiving chemotherapy: a cross-sectional study. Jpn J Clin Oncol 47(12):1157–1161
Saraste D, Järås J, Martling A (2020) Population-based analysis of outcomes with early-age colorectal cancer. Br J Surg 107(3):301–309
Schagen SB, Tsvetkov AS, Compter A, Wefel JS (2022) Cognitive adverse effects of chemotherapy and immunotherapy: are interventions within reach? Nat Rev Neurol 18(3):173–185
Selter J, Huang Y, Grossman Becht LC, Palmerola KL, Williams SZ, Forman E, Ananth CV, Hur C, Neugut AI, Hershman DL, Wright JD (2019) Use of fertility preservation services in female reproductive-aged cancer patients. Am J Obstet Gynecol 221(4):328.e321–328.e316
Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, Colvin LA, Fallon M (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain 155(12):2461–2470
Siegel RL, Jakubowski CD, Fedewa SA, Davis A, Azad NS (2020) Colorectal cancer in the young: epidemiology, prevention, management. Am Soc Clin Oncol Educ Book 40:1–14
Simard J, Kamath S, Kircher S (2019) Survivorship guidance for patients with colorectal cancer. Curr Treat Options in Oncol 20(5):38
Smith JD, Ruby JA, Goodman KA, Saltz LB, Guillem JG, Weiser MR, Temple LK, Nash GM, Paty PB (2012) Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy. Ann Surg 256(6):965–972
Spanos CP, Mamopoulos A, Tsapas A, Syrakos T, Kiskinis D (2008) Female fertility and colorectal cancer. Int J Color Dis 23(8):735–743
Teh WT, Stern C, Chander S, Hickey M (2014) The impact of uterine radiation on subsequent fertility and pregnancy outcomes. Biomed Res Int 2014:482968
Tonneau M, Elkrief A, Pasquier D, Paz Del Socorro T, Chamaillard M, Bahig H, Routy B (2021) The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: a systematic review. Radiother Oncol 156:1–9
Traa MJ, De Vries J, Roukema JA, Den Oudsten BL (2012) Sexual (dys)function and the quality of sexual life in patients with colorectal cancer: a systematic review. Ann Oncol 23(1):19–27
Vakalopoulos I, Dimou P, Anagnostou I, Zeginiadou T (2015) Impact of cancer and cancer treatment on male fertility. Hormones 14(4):579–589
van der Valk MJM, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, Beets GL, Figueiredo NL, Habr-Gama A, Perez RO, Renehan AG, van de Velde CJH (2018) Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet 391(10139):2537–2545
Wo JY, Viswanathan AN (2009) Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys 73(5):1304–1312
Zaborowski A, Stakelum A, Winter DC (2019) Systematic review of outcomes after total neoadjuvant therapy for locally advanced rectal cancer. Br J Surg 106(8):979–987
Zaborowski AM, Murphy B, Creavin B, Rogers AC, Kennelly R, Hanly A, Martin ST, O’Connell PR, Sheahan K, Winter DC (2020) Clinicopathological features and oncological outcomes of patients with young-onset rectal cancer. Br J Surg 107(5):606–612
Zaborowski AM, Abdile A, Adamina M, Aigner F, d’Allens L, Allmer C, Álvarez A, Anula R, Andric M, Atallah S, Bach S, Bala M, Barussaud M, Bausys A, Bebington B, Beggs A, Bellolio F, Bennett MR, Berdinskikh A, Bevan V, Biondo S, Bislenghi G, Bludau M, Boutall A, Brouwer N, Brown C, Bruns C, Buchanan DD, Buchwald P, Burger JWA, Burlov N, Campanelli M, Capdepont M, Carvello M, Chew HH, Christoforidis D, Clark D, Climent M, Cologne KG, Contreras T, Croner R, Daniels IR, Dapri G, Davies J, Delrio P, Denost Q, Deutsch M, Dias A, D’Hoore A, Drozdov E, Duek D, Dunlop M, Dziki A, Edmundson A, Efetov S, El-Hussuna A, Elliot B, Emile S, Espin E, Evans M, Faes S, Faiz O, Fleming F, Foppa C, Fowler G, Frasson M, Figueiredo N, Forgan T, Frizelle F, Gadaev S, Gellona J, Glyn T, Gong J, Goran B, Greenwood E, Guren MG, Guillon S, Gutlic I, Hahnloser D, Hampel H, Hanly A, Hasegawa H, Iversen LH, Hill A, Hill J, Hoch J, Hoffmeister M, Hompes R, Hurtado L, Iaquinandi F, Imbrasaite U, Islam R, Jafari MD, Kanemitsu Y, Karachun A, Karimuddin AA, Keller DS, Kelly J, Kennelly R, Khrykov G, Kocian P, Koh C, Kok N, Knight KA, Knol J, Kontovounisios C, Korner H, Krivokapic Z, Kronberger I, Kroon HM, Kryzauskas M, Kural S, Kusters M, Lakkis Z, Lankov T, Larson D, Lázár G, Lee KY, Lee SH, Lefèvre JH, Lepisto A, Lieu C, Loi L, Lynch C, Maillou-Martinaud H, Maroli A, Martin S, Martling A, Matzel KE, Mayol J, McDermott F, Meurette G, Millan M, Mitteregger M, Moiseenko A, Monson JRT, Morarasu S, Moritani K, Möslein G, Munini M, Nahas C, Nahas S, Negoi I, Novikova A, Ocares M, Okabayashi K, Olkina A, Oñate-Ocaña L, Otero J, Ozen C, Pace U, São Julião GP, Panaiotti L, Panis Y, Papamichael D, Park J, Patel S, Patrón Uriburu JC, Pera M, Perez RO, Petrov A, Pfeffer F, Phang PT, Poskus T, Pringle H, Proud D, Raguz I, Rama N, Rasheed S, Raval MJ, Rega D, Reissfelder C, Reyes Meneses JC, Ris F, Riss S, Rodriguez-Zentner H, Roxburgh CS, Saklani A, Salido AJ, Sammour T, Saraste D, Schneider M, Seishima R, Sekulic A, Seppala T, Sheahan K, Shine R, Shlomina A, Sica GS, Singnomklao T, Siragusa L, Smart N, Solis A, Spinelli A, Staiger RD, Stamos MJ, Steele S, Sunderland M, Tan KK, Tanis PJ, Tekkis P, Teklay B, Tengku S, Jiménez-Toscano M, Tsarkov P, Turina M, Ulrich A, Vailati BB, van Harten M, Verhoef C, Warrier S, Wexner S, de Wilt H, Weinberg BA, Wells C, Wolthuis A, Xynos E, You N, Zakharenko A, Zeballos J, Winter DC (2021a) Characteristics of early-onset vs late-onset colorectal cancer: a review. JAMA Surg 156(9):865–874
Zaborowski AM, Winter DC, Lynch L (2021b) The therapeutic and prognostic implications of immunobiology in colorectal cancer: a review. Br J Cancer 125(10):1341–1349
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Doogan, K., Zaborowski, A.M., Winter, D.C. (2023). Challenges of Onco-therapeutics in Early-Onset Colorectal Cancer. In: Rezaei, N. (eds) Gastrointestinal Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research, vol 4. Springer, Cham. https://doi.org/10.1007/16833_2023_148
Download citation
DOI: https://doi.org/10.1007/16833_2023_148
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-48370-7
Online ISBN: 978-3-031-48371-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)